Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor plus G-CSF for stem cell mobilization in pediatric solid tumors
NL-OMON40176Phase 2Active, not recruiting
- Sponsor
- Sanofi
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in Nonhematologic neoplasms, sponsored by Sanofi. Started Jun 2014; status: active, not recruiting.
02
Drugs
plerixafor
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on NL-OMON40176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40176.